Type 2 diabetes mellitus (T2DM) is a major global health challenge, with insulin resistance (IR) and islet dysfunction as its core pathophysiology. Current glucose-lowering agents, including insulin secretagogues, insulin sensitizers, DPP–IV inhibitors, SGLT-2 inhibitors, and GLP-1 receptor agonists, effectively contro...
Guan-Rong Qiao, O. Adejobi, Xue-Fang Li et al.· Biomolecules· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.